SecBot SecBot

STLNW

Starling Oncology, Inc.
Nasdaq· CIK 0001799191 Biotech & Drug Discovery
Warrants of Starling Oncology, Inc. · STLN stock page →
—
Market cap
$2.5M
Nano cap
1 year
+36.4%
from $4.61 · Oct 27
30 days
−5.3%
from $6.64
52-week range
$2.38–7.05
−11% from high · low Feb 12
Avg volume 20D
1.20M
shares / day
Short interest
🔒 Subscribers only
New fund stakes
0
Q2 2026 13F · 0 exits

Price

Daily candles with volume. Pins mark insider trades, rating changes, 13F stakes, reports, catalysts and short-interest jumps.

  • X Sep 30 Short interest jumps 27.9% to 8.7K

Signal stack

Where each data set points today.

  • InstitutionsMIXED

    Q2 2026: 1 added (0 new), 0 trimmed or exited.

  • TrendDOWNTREND

    3% below its 50-day average.

Who's buying

13F· Q2 2026
0
new positions
0
exits
FundMoveSharesValue
WOLVERINE ASSET MANAGEMENT LLCDOUBLED418,214$17.1K
WOLVERINE ASSET MANAGEMENT LLCDOUBLED191,565$9.8K
Walleye Capital LLCNEAR_EXIT53,902$280.00
UBS Group AGTRIM3,106$16.00
BANK OF AMERICA CORP /DE/TRIM200$1.00
BANK OF AMERICA CORP /DE/TRIM499$10.00

Quarterly 13F filings are due 45 days after each quarter ends.

Catalysts
Scheduled dates and disclosed events: earnings, FDA and trial readouts, halts, press releases. Colored dot = impact.
Recent

Earnings setup

Estimates

Revision history: 🔒 Fresh data, subscribers only

PeriodEPS est.Range30D rev.Revenue
Current Q🔒 Fresh data, subscribers only
Next Q🔒 Fresh data, subscribers only
Current FY🔒 Fresh data, subscribers only
Next FY🔒 Fresh data, subscribers only

Short side

FINRA· Oct 15, 2026
🔒 Subscribers only
shares short
Recent activity
The latest filings, insider trades, analyst actions, press and options flow — newest first.
Aug 4, 2026 Listing status
New Listing: STLNW — Starling Oncology Institute, Inc. - Warrant
Listed on exchange Q
Jun 30, 2026 Inst.
WOLVERINE ASSET MANAGEMENT LLC — DOUBLED
418,214 shares ($17.1K)
Jun 30, 2025 Inst.
WOLVERINE ASSET MANAGEMENT LLC — DOUBLED
191,565 shares ($9.8K)